Literature DB >> 18339330

MH1 domain of SMAD4 binds N-terminal residues of the homeodomain of Hoxc9.

Bo Zhou1, Lihong Chen, Xing Wu, Jing Wang, Yinliang Yin, Guang Zhu.   

Abstract

Smad family proteins mediate signaling initiated by bone morphogenetic proteins (BMPs). Upon BMP stimulation, the Smads such as Smad4 can interact directly with Hox proteins and suppress their DNA-binding activity. Although the interaction between the MAD-homology 1 (MH1) domain of Smad4 and Hox was found to regulate the transcription activity of Hox proteins, the molecular mechanism is not well characterized and direct contact residues remain to be elucidated. In the present study, the interaction between the recombinant homeodomain (HD) of Hoxc9 and MH1 domain of Smad4 was investigated with the use of the GST pull-down assay, surface plasmon resonance (SPR) analysis as well as multidimensional nuclear magnetic resonance (NMR) techniques. The Hoxc9-HD was precipitated with the GST-fused Smad4-MH1 but not with GST alone, demonstrating a direct interaction between Hoxc9-HD and Smad4-MH1 in vitro. SPR measurement further confirmed a moderately strong interaction (K(d) approximately 400 nM) between these two domains. Moreover, NMR titration experiments showed that a strong and specific binding occurred between Smad4-MH1 and Hoxc9-HD. NMR triple-resonance experiments and backbone assignments revealed that the N-terminal arm of Hoxc9-HD, spanning the positive-charged DNA-binding segment of Arg190-Arg196, was intimately involved in the interaction with Smad4-MH1. Ala-substitutions of Arg190-Arg196 led to the loss of interaction between Hoxc9-HD and Smad4-MH1 in both GST-pull down assay and SPR analysis; further provided functional evidence for the critical role of this positive-charged region in binding to Smad4-MH1. This suggested that Smad4-MH1 could occupy one of the DNA binding sites of Hoxc9 and consequently inhibits its transcription activity. The above results are in good agreement and yield the first insight into the interaction between the homeodomain of Hox proteins and the conserved MH1 domain of Smad family proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339330     DOI: 10.1016/j.bbapap.2008.01.021

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  TGIF1 homeodomain interacts with Smad MH1 domain and represses TGF-β signaling.

Authors:  Ewelina Guca; David Suñol; Lidia Ruiz; Agnieszka Konkol; Jorge Cordero; Carles Torner; Eric Aragon; Pau Martin-Malpartida; Antoni Riera; Maria J Macias
Journal:  Nucleic Acids Res       Date:  2018-09-28       Impact factor: 16.971

2.  Homeobox C9 is not potentially related to congenital heart disease in Chinese patients.

Authors:  Lei Sun; Longfei Cheng; Congmin Li; Bingren Gao; Binbin Wang; Jing Wang; Xiaochen Wang; Tianchu Huang; Hui Li; Xu Ma
Journal:  Genet Test Mol Biomarkers       Date:  2011-11-22

3.  Smad7 protein induces interferon regulatory factor 1-dependent transcriptional activation of caspase 8 to restore tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis.

Authors:  Suntaek Hong; Hye-Youn Kim; Jooyoung Kim; Huyen Trang Ha; Young-Mi Kim; Eunjin Bae; Tae Hyung Kim; Kang Choon Lee; Seong-Jin Kim
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

Review 4.  Hox specificity unique roles for cofactors and collaborators.

Authors:  Richard S Mann; Katherine M Lelli; Rohit Joshi
Journal:  Curr Top Dev Biol       Date:  2009       Impact factor: 4.897

5.  Gene Regulatory Mechanisms Underlying the Spatial and Temporal Regulation of Target-Dependent Gene Expression in Drosophila Neurons.

Authors:  Anthony J E Berndt; Jonathan C Y Tang; Marc S Ridyard; Tianshun Lian; Kathleen Keatings; Douglas W Allan
Journal:  PLoS Genet       Date:  2015-12-29       Impact factor: 5.917

6.  HOXC6 gene silencing inhibits epithelial-mesenchymal transition and cell viability through the TGF-β/smad signaling pathway in cervical carcinoma cells.

Authors:  Feng Zhang; Chen-Chen Ren; Ling Liu; Yan-Nan Chen; Li Yang; Xiao-An Zhang
Journal:  Cancer Cell Int       Date:  2018-12-12       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.